A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus
Clinical trial NCT07001839 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07001839
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2026-12-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.